Arch's new mortgage ILS deal shows signs of post-COVID rebound
Arch Capital Group's US mortgage insurance operation Arch Mortgage Insurance Company (Arch MI) has completed its second mortgage insurance linked note (MILN) deal of 2021, at the "best pricing" and broadest investor participation for any Bellemeade programme so far.
Arch MI obtained over $616 million of indemnity reinsurance on a pool representing approximately $36 billion of mortgages from Bellemeade Re 2021-2, a special purpose reinsurer.
The coverage was obtained by issuing approximately $523 million in bonds and $93 million in direct reinsurance. It covered a portfolio of MI policies issued by Arch MI and affiliates between December 2020 and March 2021.
The deal represented Bellemeade’s 16th since the programme’s inception in 2015. It was the second Bellemeade transaction to use the Secured Overnight Financing Rate (SOFR) as the benchmark rate for pricing instead of the London Inter-Bank Offered Rate (LIBOR).
The company explained that the market for mortgage ILN has recovered from the risks associated with the pandemic.
“This transaction’s execution represents the broadest investor participation at the best pricing for current exposure in the Bellemeade program’s history,” said Jim Bennison, EVP, Alternative Markets for Arch MI. “We believe investors have concluded that the risks associated with the COVID-19 pandemic are behind us.”
Bellemeade Re 2021-2 is funding its reinsurance obligations through the issuance of five classes of amortising notes with 10-year legal final maturities. These included $194,532,000 class M-1A notes with a coupon equal to one-month SOFR plus 120 basis points; $93,334,000 class M-1B notes with a coupon equal to one-month SOFR plus 150 basis points; $97,265,000 class M-1C notes with a coupon equal to one-month SOFR plus 185 basis points; $105,704,000 class M-2 notes with a coupon equal to one-month SOFR plus 290 basis points; and $31,972,000 class B-1 notes with a coupon equal to one-month SOFR plus 415 basis points.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze